Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?
Harper
S E
SE
Gastrointestinal Unit, Massachusetts General Hospital, Boston, USA.
Dienstag
J L
JL
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control*; D002908:Chronic Disease; D006505:Hepatitis / Q000150:complications*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000517:prevention & control*; D011446:Prospective Studies
D000970:Antineoplastic Agents; D016898:Interferon-alpha